Xtant Medical

News

Xtant Medical Names Sean Browne President and Chief Executive Officer

BELGRADE, Mont. , Oct. 07, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Sean Browne as President and Chief Executive Officer,
Read more

Xtant Medical Announces Second Quarter 2019 Financial Results

BELGRADE, Mont. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2019
Read more

Xtant Medical Announces First Quarter 2019 Financial Results

BELGRADE, Mont. , May 15, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2019 .
Read more

Xtant Medical Receives Noncompliance Notice from NYSE American

BELGRADE, Mont. , April 05, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced receipt of notification from the NYSE American that the Company is not in
Read more

Xtant Medical Announces Fourth Quarter and 2018 Financial Results

BELGRADE, Mont. , April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended
Read more

Xtant Medical Announces Amendments and Extension of Credit Facility

BELGRADE, Mont. , April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has executed the Second Amended and Restated Credit Agreement
Read more